These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19435752)

  • 1. Erythrocyte membrane fatty acids in patients with multiple sclerosis.
    Hon GM; Hassan MS; van Rensburg SJ; Abel S; Marais DW; van Jaarsveld P; Smuts CM; Henning F; Erasmus RT; Matsha T
    Mult Scler; 2009 Jun; 15(6):759-62. PubMed ID: 19435752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis.
    Hon G; Hassan M; van Rensburg SJ; Abel S; Marais de W; van Jaarsveld P; Smuts C; Henning F; Erasmus R; Matsha T
    Br J Nutr; 2009 Nov; 102(9):1334-40. PubMed ID: 19454128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Walking capacities in multiple sclerosis measured by global positioning system odometer.
    Créange A; Serre I; Levasseur M; Audry D; Nineb A; Boërio D; Moreau T; Maison P;
    Mult Scler; 2007 Mar; 13(2):220-3. PubMed ID: 17439888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
    Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
    Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.
    Rezapour-Firouzi S; Arefhosseini SR; Ebrahimi-Mamaghani M; Farhoudi M; Baradaran B; Ali TM; Zamani F
    Afr J Tradit Complement Altern Med; 2013; 10(6):519-27. PubMed ID: 24311880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
    Vogt MH; Lopatinskaya L; Smits M; Polman CH; Nagelkerken L
    Ann Neurol; 2003 Jun; 53(6):819-22. PubMed ID: 12783433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.
    Abo-Krysha N; Rashed L
    Mult Scler; 2008 Jun; 14(5):602-8. PubMed ID: 18408021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
    Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
    Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
    J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.
    Gray OM; Abdeen H; McDonnell GV; Patterson CC; Graham CA; Hawkins SA
    Mult Scler; 2009 Mar; 15(3):299-303. PubMed ID: 19244395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
    Caramanos Z; DiMaio S; Narayanan S; Lapierre Y; Arnold DL
    J Neurol Sci; 2009 Jul; 282(1-2):72-9. PubMed ID: 19232641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue, depression and progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
    Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
    Minneboo A; Uitdehaag BM; Jongen P; Vrenken H; Knol Dl; van Walderveen MA; Polman CH; Castelijns JA; Barkhof F
    Mult Scler; 2009 May; 15(5):632-7. PubMed ID: 19389751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.
    Debouverie M; Laforest L; Van Ganse E; Guillemin F;
    Mult Scler; 2009 Feb; 15(2):251-7. PubMed ID: 19181774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy.
    Yang G; Qiu H; Wang S; Deng H; Zhang S; Li L
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):407-12. PubMed ID: 10862451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
    An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
    J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis.
    Jung P; Beyerle A; Ziemann U
    Mult Scler; 2008 May; 14(4):553-6. PubMed ID: 18562509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity correlates with neurological impairment and disability in multiple sclerosis.
    Motl RW; Snook EM; Wynn DR; Vollmer T
    J Nerv Ment Dis; 2008 Jun; 196(6):492-5. PubMed ID: 18552627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.